Differential modulation of murine lung inflammation by bradykinin B 1 and B 2 selective receptor antagonists

Author： Gama Landgraf R.   Sirois P.   Jancar S.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.460, Iss.1, 2003-01, pp. : 75-83

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bradykinin B1 receptor antagonists

By  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 9, 2001-09 ,pp. : 1479-1482

Informa Healthcare

Access to resources Recommend Favorite

Bradykinin B1 receptor antagonists: a patent update 2009 – 2012

By Bozó Éva   Éles János   Keserű György M  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 12, 2012-12 ,pp. : 1443-1452

Informa Healthcare

Access to resources Recommend Favorite

Characterization of bradykinin B 2 receptor antagonists in human and rat urinary bladder

By Meini S.   Patacchini R.   Giuliani S.   Lazzeri M.   Turini D.   Maggi C.A.   Lecci A.  

European Journal of Pharmacology, Vol. 388, Iss. 2, 2000-01 ,pp. : 177-182

Elsevier

Access to resources Recommend Favorite

Non-peptide Antagonists and Agonists of the Bradykinin B2 Receptor

By  

Current Medicinal Chemistry, Vol. 9, Iss. 9, 2002-05 ,pp. : 913-928

Bentham Science Publishers

Access to resources Recommend Favorite

NR2B Selective NMDA Receptor Antagonists

By  

Current Pharmaceutical Design, Vol. 8, Iss. 10, 2002-05 ,pp. : 845-855

Bentham Science Publishers

Access to resources Recommend Favorite